InsidersTradesSigma
Track the 셀로맥스사이언스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀로맥스사이언스 has logged 15 reports. Market capitalisation: €45.4bn. The latest transaction was disclosed on 7 April 2026 (Purchase). Among the most active insiders: 서정민. The full history is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,973 of 29,064 companies
66.5
score / 100
Value61
Quality72
FCF yld3.5%
Earn yld6.5%
EV/EBITDA11.5x
ROE7.6%
Gross mgn48%
Net mgn13%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
Declarations15 total
385,328 sharesKRXDART:20241217000406
15 of 15 declarations
关于 셀로맥스사이언스
Cellomax Science 是一家在 XKRX 市场上市的医疗保健和制药公司。该公司专注于在生命科学领域开发创新解决方案。